Abstract. High sensitivity quantification of the putative cell-penetrating peptide diarginine-histidine (RRH) associated with poly (ethyl-cyanoacrylate) (PECA) nanoparticles was achieved without analyte separation, using a novel application of isobarictagging and high matrix-assisted laser desorption/ionization coupled to time-of-flight (MALDI-TOF) mass spectrometry. Isobaric-tagging reaction equilibrium was reached after 5 min, with 90% or greater RRH peptide successfully isobaric-tagged after 60 min. The accuracy was greater than 90%, which indicates good reliability of using isobarictagged RRH as an internal standard for RRH quantification. The sample intra-and inter-spot coefficients of variations were less than 11%, which indicate good repeatability. The majority of RRH peptides in the nanoparticle formulation were physically associated with the nanoparticles (46.6%), whereas only a small fraction remained unassociated (13.7%). The unrecovered RRH peptide (~40%) was assumed to be covalently associated with PECA nanoparticles.
Introduction P olymeric nano-carriers continue to be investigated as candidates for the oral delivery of therapeutic peptides and proteins [1] . Recently, the surfaces of polymeric nano-carriers have been modified with cell-penetrating peptides (CPPs) with the aim of enhancing oral absorption [2] . We have demonstrated that surface decoration with CPP di-arginine-histidine (RRH) peptide significantly increased the in vitro cellular uptake of poly (ethyl-cyanoacrylate) (PECA) nanoparticles [3] . Matrix-assisted laser desorption/ionisation coupled to time-of-flight (MALDI-TOF) mass analysis showed that the RRH peptide was covalently associated with the PECA nanoparticles [3] . However, the amount of RRH peptide associated with the nanoparticles has yet to be quantified.
Unlike high performance liquid chromatography (HPLC), MALDI-TOF mass spectrometry allows the direct analysis of large intact bioactives without the need for analyte separation prior to analysis [4] . However, peptide quantification with MALDI-TOF mass spectrometry can be difficult due to the signal-to-signal suppression and the unreliability of using analyte signal to noise ratio for quantification purposes. Therefore, quantification with MALDI-TOF mass spectrometry requires the use of an internal standard [5] . To ensure the internal standard and peptide analyte have similar ionisation efficiencies and distributions within a sample matrix, the internal standard used must be of similar chemical composition and mass to the peptide analyte [5, 6] or be composed of isotopic-labeled analyte [7] . Alternatively, peptide analyte can be isobaric-tagged with i-TRAQ (Isobaric Tags for Relative and Absolute Quantification) to provide an internal standard [8] . The i-TRAQ tag (4-plex) consists of a charged reporter group (to differentiate between different i-TRAQ tags), a peptide reactive group (to covalently tag the peptide N-terminus) and a neutral balancer group (composed of  different isotopic   13   C,   15   N, and   18 O atoms to maintain an overall tag mass of 145). The use of i-TRAQ in mass spectrometry quantification also reduces signal-to-signal suppression as the signal peaks of the analyte and internal standard generate a single combined peak of higher intensity in the mass spectrum [9] .
For quantification of the RRH peptide associated physically (noncovalently) with PECA nanoparticles, RRH-decorated nanoparticles can be prepared from isobaric-tagged RRH peptide and then spiked with a known concentration of isobaric-tagged RRH peptide of a different reporter group (internal standard). Upon fragmentation of the isobaric-tagged RRH precursor, reporter groups with different masses will be generated. Therefore, the RRH peptide associated noncovalently with the nanoparticles in the sample can be quantified via the signal intensity ratio between the reporter groups (RRH peptide used in the sample preparation versus the internal standard).
Here, we applied MALDI-TOF mass spectrometry with isobaric tagging to quantify the proportion of the cell-penetrating peptide (RRH) noncovalently associated with PECA nanoparticles and estimated covalent binding by mass balance.
Experimental

Isobaric-Tagging of RRH Peptide
Isobaric-tagging of RRH peptide (≥95% purity; GLS, Shanghai, China) was carried out by dissolving RRH peptide (50 μg) in 20 μL of 0.5 M triethylammonium bicarbonate buffer. This solution was then mixed with the contents of a single i-TRAQ reagent vial (Sciex, Framingham, MA, USA) reconstituted in 70 μL ethanol. A second and third batch of RRH peptide (50 μg each) was also prepared with i-TRAQ reagents of different mass reporters to be used as the internal standards using the same procedures. The isobaric-tagged RRH (RRHi) peptides were then kept at room temperature for 60 min to allow the isobaric-tagging reaction to complete [8] . The RRHi peptides were then freezedried for 24 h and stored at -80°C until required. MALDI matrix was prepared with 98% α-cyano-4-hydroxycinnamic (10 mg/mL in 60% (v/v) acetonitrile), 1% ammonia phosphate (1 M), and 1% trifluoroacetic acid (10% TFA in 60% (v/v) acetonitrile).
To compare the isobaric-tagging efficiency between different tags (114, 115, and 116), 1.0 μL of each reconstituted RRHi peptide batch was mixed together in equimolar proportions in 40 μL acetonitrile. An aliquot of this mixture (1.0 μL) was added to 9.0 μL of MALDI matrix and mixed thoroughly prior to mass spectrometry (MS) analysis. To investigate the isobaric-tagging of the RRH peptide, 1.0 μL of the reconstituted RRHi peptide (485 μg/mL) was mixed with 40 μL acetonitrile. The sample was then spiked with 1.0 μL of 5%, 10%, or 20% of the 50 μg RRH peptide initially used for isobaric-tagging. An aliquot (1.0 μL) of the sample spiked with RRH peptide was mixed with 9.0 μL of MALDI matrix prior to MS analysis.
Preparation of RRH-Decorated Nanoparticles
RRH-decorated nanoparticles were prepared by the microemulsion method described by Chiu et al. [3] . Briefly, a mixture of Span 20 and Tween 80 was prepared at a weight ratio of 4:6. Then the surfactant blend and ethyl oleate were mixed together at a weight ratio of 5.4:3.6. The RRHi (50 μg) was reconstituted in 103 μL ultra-pure water (485 μg/mL). To prepare 1.0 g of microemulsion template, 100 μL of reconstituted RRH peptide tagged with i-TRAQ 114, RRHi 114 (water phase) was added to 0.9 g of the surfactant and ethyl oleate mix. ECA monomers were added drop-wise to the microemulsion template stirred at 700 rpm at 4°C. The polymerization process was allowed to progress for a minimum of 4 h.
Preparation of Nanoparticle Samples for Mass Analysis
RRH-decorated nanoparticles were isolated from 0.3 g microemulsion (mixed with 0.5 mL 80% (v/v) methanol and 0.5 mL acidified ultra-pure water (pH 2.5)) by centrifugation (20,800 g) for 30 min. The pellet was resuspended via brief sonication in absolute ethanol (0.5 mL) to wash the isolated nanoparticles. The nanoparticles were later spun at 20,800 g for 30 min. This washing step was repeated twice. The microemulsion supernatant and the ethanol supernatant (combined from both washes) were collected, while the isolated nanoparticle pellet was dissolved in 0.2 mL acetonitrile. An aliquot of these collected samples (40 μL) was spiked with the internal standard RRHi 115 peptide. The spiked sample (1.0 μL) was then mixed with 4.0 μL MALDI matrix. The spiked sample matrix (5.0 μL) was mixed with 5.0 μL MALDI matrix spiked with a second internal standard (RRHi 116 ) of equimolar concentration to RRHi 115 .
MALDI-TOF Mass Spectrometry Acquisition
An aliquot (0.5 μL) of the MALDI samples was spotted on the MALDI-plate (Opti-TOF 384 well plate; Applied Biosystems, Framingham, MA, USA) for mass analysis. Spotted samples were immediately vacuum-dried at 60°C for 2 min to ensure a homogenous sample distribution. All mass spectrometry was undertaken on a 4800 MALDI tandem time-of-flight mass spectrometer (Applied Biosystems, Framingham, MA, USA). All mass spectra were obtained in positive-ion reflector mode with 8000 laser pulses (40 sub-spectra from 200 shots each) per sample spot. Relevant precursor ions were chosen for collision-induced dissociation tandem mass spectrometry (CID-MS/MS). Laser pulses were then set at 8000 (40 sub-spectra from 200 shots each) per selected precursor using 2 kV mode and air as the collision gas at a pressure of 1 × 10 -6 Torr. All mass spectra were obtained with laser pulses fired randomly across the sample spot and processed using 4000 Series Explorer (version 3.5) provided by Applied Biosystems. The analyte peak heights (pixels) in the mass spectra were manually determined using Microsoft Paint (version 6.1).
Quantification of RRHi 114 Recovered from Nanoparticles
Quantification of RRHi 114 peptide in the nanoparticle sample was performed by calculating the ratio of the signal intensities for mass reporters of i-TRAQ 114 (sample) and 115 (internal standard) (Equation 1). The recovered proportion of RRHi 114 in each sample was calculated using (Equation 2). where mr = mass peptide recovered and ma = total mass peptide added in the formulation.
Accuracy and Variability
The accuracy was calculated based on the recovery of RRHi 115 peptide (internal standard) spiked in microemulsion, ethanol or acetonitrile (3).
Accuracy % ð Þ ¼ mr 115 =ms 115 Â 100 ð3Þ
where mr = RRHi 115 mass peptide recovered and ms = mass of RRHi 115 peptide spiked. The mass of RRHi 115 peptide recovered (mr 115 ) was quantified based on the signal intensity ratio of the mass reporters of i-TRAQ 115 (internal standard) and 116 (second internal standard).
The variability was determined by comparing the signal intensity ratio of the mass reporters of i-TRAQ 115 and 116. For intra-spot variability, a single spot was measured three times. For inter-spot variability, a sample was spotted on three different spots on the MALDI-plate.
Accuracy and variability were determined for samples prepared in microemulsion, ethanol, and acetonitrile at RRHi 115 peptide concentrations in the range of those used to quantify RRHi 114 peptide.
Results and Discussion
The isobaric-tagging reaction kinetics reached equilibrium after 10 min (Supplementary Figures S1 and S2 ) indicated by no further change in the ratio of RRH/Total RRH or RRHi/Total RRHi (Supplementary Figure S2) . The RRH peptide peak was observed with reconstituted RRHi spiked with 10% or greater RRH (Supplementary Figure S3) and the lack of RRH peptide peak after 60 min of isobaric-tagging (Supplementary Figure S1h) suggests that 10% or less of the RRH peptide remains untagged.
To distinguish between the RRH peptide tagged with various i-TRAQ tags, the RRHi precursor (612 m/z) was selected for CID fragmentation to produce different i-TRAQ mass reporter groups, 114, 115, and 116 (Supplementary Figure S4) . The mass peaks of different reporters were then normalized against the reporter with the highest peak intensity (Supplementary Table S1 ). By mixing an equimolar concentration of RRH peptide tagged with each i-TRAQ (114, 115, and 116), the proportion of RRH peptide that was isobaric-tagged in each batch could be compared (Supplementary Figure S4) . The tagging efficiency was very similar for all tags, with all efficiencies being greater than 90% (Supplementary Table S1 ).
Other mass peaks were obtained from the fragmentation of the RRHi precursor (612 m/z) in addition to the reporter groups (Supplementary Figure S4) . The peaks were m/z 312, which represents the mass of arginine-histidine [M RH (311) + H] + and m/z 457, which represents the isobaric-tagged di-arginine fragment [M RR (312) + M i-TRAQ (145)]. The mass peak m/z 475 was observed because of the rearrangement that occurred during fragmentation where the C-terminal residue of arginine was lost, but the C-terminal OH group plus a proton (total mass of 18) were transferred to the m/z 457 fragment ion. This phenomenon is common in the CID of peptide ions that lack a mobile proton, such as arginine [10] . The mass peak m/z 415 is the RRHi fragment ion with both arginine side chains (2 × C 4 N 3 H 8 ) cleaved. As the collision energy used in the experiment was higher than 1 kV, the resulting MS/MS spectra can contain d-, v-, and w-type fragment ions, where the amino acid side chains are partially or fully fragmented [10] . The mass peak m/z 415 is otherwise known as the v-type fragment ion, where the entire amino acid side chain is lost. The mass peak m/z 570 could potentially be RRH fragment ion with cyanamide group (CN 2 H 2 ) cleaved. The loss of cyanamide group from arginine has also been reported for high energy CID fragmentation of glycine-arginine peptide isomer [11] and acylarginine peptide [12] .
The proportions (%) of RRHi 114 peptide recovered (Equation 2) in the supernatant of the microemulsion (Figure 1a ) and the ethanol washes ( Figure 1b) were considered as RRHi 114 peptide unassociated with the nanoparticles (9.4% ± 4.6% and 4.3% ± 0.3%, respectively). The proportion (%) of RRHi 114 peptide recovered from the dissolved RRH-tagged nanoparticle sample (Figure 1c ) was considered to be RRHi 114 peptide physically associated with the nanoparticles (46.6% ± 5.6%). The accuracy of the assay (Equation 3) was between 90% and 105% (Supplementary Table S2 ), which indicates good reliability of using internal standard RRHi 115 for the quantification of RRHi 114 in the nanoparticle samples. The intra-and inter-spot coefficient variations were within 11% across all samples, (Supplementary Table S3 ).
The unassociated RRH peptide in the supernatant of the microemulsion matrix determined by MALDI-TOF mass spectrometry was 9.4% ± 4.6% in agreement with the result of 11.9% ± 3.5% determined using reversed phase (RP)-HPLC-UV assay [3] . In addition, MALDI-TOF mass spectrometry with isobarictagging was more sensitive than RP-HPLC-UV as we were able to quantify 0.2 μg/mL of RRH peptide in microemulsion matrix compared with the RP-HPLC-UV assay that had a detection limit of 0.8 μg/mL [3] .
The fragmented precursor of m/z 988 yielded a prominent mass peak of RRHi 114 peptide at m/z 612, which confirms the covalent association of RRHi 114 peptide with 3 ECA monomer units (m/z 988; [M RRHi114 (612) + M ECA (125) 3 Figure 2) . A similar result was also observed on fragmentation of the precursor of RRHi 114 peptide bound to 1 ECA monomer unit (m/z 738) (data not shown). These findings confirmed that isobaric-tagging of the RRH peptide with i-TRAQ did not prevent the RRH peptide from covalently associating with the PECA polymer. This finding was expected because the RRH peptide covalently associates with PECA nanoparticles via the imidazole ring of the histidine [3] instead of at the Nterminus of the arginine, where the isobaric-tagging occurs.
Direct quantification of covalently associated RRHi 114 peptide with PECA polymer is complicated because RRHi 114 can associate with polymer blocks of different lengths and would, therefore, require the synthesis of multiple RRHi 114 peptide covalently bound with specific chain lengths of PECA polymer to be used as internal standards. Therefore, an indirect mass balance approach was taken in that the unrecovered portion of the RRHi 114 peptide (~40%) was assumed to be covalently associated to PECA nanoparticles. The presence of RRH peptide covalently associated to the PECA polymer may help to explain the positive shift in Zeta-potential (+18 mV) of the PECA nanoparticles that have a negative charge (-14 mV) when not decorated with cellpenetrating peptides [3] .
Conclusions
We have shown that peptide quantification with polymeric nanoparticles can be performed using isobaric-tagging and MALDI-TOF mass analysis without the need for analyte separation. This technique has a high sensitivity and is a valuable analytical tool for the characterization of functional peptides or proteins associated with nanoparticles.
